Guillermo Méndez

5.1k total citations
58 papers, 1.1k citations indexed

About

Guillermo Méndez is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Guillermo Méndez has authored 58 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 18 papers in Surgery and 15 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Guillermo Méndez's work include Gastric Cancer Management and Outcomes (10 papers), Bacterial Genetics and Biotechnology (9 papers) and Colorectal Cancer Treatments and Studies (8 papers). Guillermo Méndez is often cited by papers focused on Gastric Cancer Management and Outcomes (10 papers), Bacterial Genetics and Biotechnology (9 papers) and Colorectal Cancer Treatments and Studies (8 papers). Guillermo Méndez collaborates with scholars based in Spain, Argentina and United States. Guillermo Méndez's co-authors include Jürg Stebler, Krasimir Slanchev, Erez Raz, Belén Pimentel, Manuel Cano, Ramón Díaz‐Orejas, Enrique Roca, Mark A. Madine, Rolf Boelens and Juan Manuel O’Connor and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Guillermo Méndez

56 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guillermo Méndez Spain 19 437 335 258 208 145 58 1.1k
Miao Pan United States 19 181 0.4× 995 3.0× 52 0.2× 126 0.6× 14 0.1× 38 1.5k
Christian Maueröder Germany 21 95 0.2× 493 1.5× 60 0.2× 87 0.4× 30 0.2× 28 1.4k
Hiroko Hoshi Japan 17 83 0.2× 613 1.8× 204 0.8× 117 0.6× 13 0.1× 39 1.2k
Scott S. Graves United States 22 161 0.4× 276 0.8× 157 0.6× 152 0.7× 32 0.2× 59 1.4k
Krishna Murari Sinha United States 20 187 0.4× 790 2.4× 89 0.3× 54 0.3× 11 0.1× 32 1.0k
Charlotte Widberg Australia 8 99 0.2× 370 1.1× 37 0.1× 56 0.3× 27 0.2× 9 717
M J Yezzi United States 8 116 0.3× 524 1.6× 81 0.3× 45 0.2× 30 0.2× 12 1.2k
Stanley Friedman United States 18 386 0.9× 842 2.5× 58 0.2× 222 1.1× 5 0.0× 28 1.4k
Rajesh Jayachandran Switzerland 11 56 0.1× 419 1.3× 65 0.3× 40 0.2× 40 0.3× 20 909
Johanna C. vanderSpek United States 18 146 0.3× 509 1.5× 197 0.8× 73 0.4× 5 0.0× 30 1.0k

Countries citing papers authored by Guillermo Méndez

Since Specialization
Citations

This map shows the geographic impact of Guillermo Méndez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guillermo Méndez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guillermo Méndez more than expected).

Fields of papers citing papers by Guillermo Méndez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guillermo Méndez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guillermo Méndez. The network helps show where Guillermo Méndez may publish in the future.

Co-authorship network of co-authors of Guillermo Méndez

This figure shows the co-authorship network connecting the top 25 collaborators of Guillermo Méndez. A scholar is included among the top collaborators of Guillermo Méndez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guillermo Méndez. Guillermo Méndez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Méndez, Guillermo, Joseph Chao, Radim Němeček, et al.. (2024). First-Line Nivolumab and Relatlimab Plus Chemotherapy for Gastric or Gastroesophageal Junction Adenocarcinoma: The Phase II RELATIVITY-060 Study. Journal of Clinical Oncology. 42(17). 2080–2093. 27 indexed citations
2.
3.
Iseas, Soledad, Guillermo Méndez, Marcela Carballido, et al.. (2023). Prognostic Factors of Long-Term Outcomes after Primary Chemo-Radiotherapy in Non-Metastatic Anal Squamous Cell Carcinoma: An International Bicentric Cohort. Biomedicines. 11(3). 791–791. 3 indexed citations
4.
Moehler, Markus, Jaffer A. Ajani, Thomas Zander, et al.. (2021). 1381P Adjuvant nivolumab in resected esophageal or gastroesophageal junction cancer (EC/GEJC) following neoadjuvant chemoradiotherapy (CRT): 14-month follow-up of CheckMate 577. Annals of Oncology. 32. S1045–S1046. 5 indexed citations
5.
Camandaroba, Marcos Pedro Guedes, Erika Ruíz‐García, Guillermo Méndez, et al.. (2021). Outcomes of Patients With Metastatic Anal Cancer According to HIV Infection: A Multicenter Study by the Latin American Gastrointestinal Oncology Group (SLAGO). Clinical Colorectal Cancer. 20(4). 299–304. 4 indexed citations
6.
Iseas, Soledad, et al.. (2021). Better quality of life and reduced fecal incontinence in rectal cancer patients with the watch-and-wait follow-up strategy. SHILAP Revista de lepidopterología. 86(4). 340–347. 9 indexed citations
7.
Kelly, Ronan J., Jaffer A. Ajani, Thomas Zander, et al.. (2020). LBA9_PR Adjuvant nivolumab in resected esophageal or gastroesophageal junction cancer (EC/GEJC) following neoadjuvant chemoradiation therapy (CRT): First results of the CheckMate 577 study. Annals of Oncology. 31. S1193–S1194. 37 indexed citations
8.
Roca, Enrique, et al.. (2020). Analysis of long-term oncological results of clinical versus pathological responses after neoadjuvant treatment in locally advanced rectal cancer. World Journal of Surgical Oncology. 18(1). 313–313. 12 indexed citations
9.
Bermejo‐Rodríguez, Camino, et al.. (2019). Targeted Cancer Cell Killing by Highly Selective miRNA-Triggered Activation of a Prokaryotic Toxin–Antitoxin System. ACS Synthetic Biology. 8(8). 1730–1736. 6 indexed citations
10.
Novick, Diego, Guillermo Méndez, Marcela Carballido, et al.. (2019). Retrospective analysis of patients with locally advanced or metastatic gastric cancer in Argentina. SHILAP Revista de lepidopterología. 19(8). e7693–e7693. 1 indexed citations
11.
Ginn, Rachel, et al.. (2019). Delays in Coccidioidomycosis Diagnosis and Relationship to Healthcare Utilization, Arizona, USA1. Emerging infectious diseases. 25(9). 1742–1744. 20 indexed citations
12.
Iseas, Soledad, et al.. (2016). P-127 Pathological versus clinical complete responders after preoperative treatment in rectal cancer: long term outcomes analysis. Annals of Oncology. 27. ii37–ii37. 1 indexed citations
13.
14.
Cano, Manuel, et al.. (2015). ‘Smartening’ anticancer therapeutic nanosystems using biomolecules. Current Opinion in Biotechnology. 35. 135–140. 14 indexed citations
15.
Belli, Susana, Adriana Oneto, Juan Manuel O’Connor, et al.. (2009). Chromogranin A as a biochemical marker for the management of neuroendocrine tumors: a multicenter study developed in Argentina.. PubMed. 39(3). 184–9. 16 indexed citations
16.
Méndez, Guillermo & Belén Pimentel. (2007). Gene and cell survival: lessons from prokaryotic plasmid R1. EMBO Reports. 8(5). 458–464. 35 indexed citations
17.
Slanchev, Krasimir, Jürg Stebler, Guillermo Méndez, & Erez Raz. (2005). Development without germ cells: The role of the germ line in zebrafish sex differentiation. Proceedings of the National Academy of Sciences. 102(11). 4074–4079. 270 indexed citations
18.
Méndez, Guillermo. (2003). Regulatable killing of eukaryotic cells by the prokaryotic proteins Kid and Kis. The EMBO Journal. 22(2). 246–251. 58 indexed citations
19.
Hargreaves, David, Sandra Santos‐Sierra, Rafael Giraldo, et al.. (2002). Structural and Functional Analysis of the Kid Toxin Protein from E. coli Plasmid R1. Structure. 10(10). 1425–1433. 69 indexed citations
20.
Santamarı́a, David, et al.. (1998). DnaB Helicase Is Unable to Dissociate RNA-DNA Hybrids. Journal of Biological Chemistry. 273(50). 33386–33396. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Miao Pan Breakdown of academic impact, for papers by Christian Maueröder Breakdown of academic impact, for papers by Hiroko Hoshi Breakdown of academic impact, for papers by Scott S. Graves Breakdown of academic impact, for papers by Krishna Murari Sinha Breakdown of academic impact, for papers by Charlotte Widberg Breakdown of academic impact, for papers by M J Yezzi Breakdown of academic impact, for papers by Stanley Friedman Breakdown of academic impact, for papers by Rajesh Jayachandran Breakdown of academic impact, for papers by Johanna C. vanderSpek
Rankless by CCL
2026